Brian Biesman, MD, FACS

Nashville Center for Laser and Facial Surgery
Nashville, TN
USA 37203
Papers:
Treatment of Moderate-to-Severe Glabellar Lines with Relabotulinumtoxina, a New Liquid Botulinum Toxin: Clinical Efficacy and Safety Results from the Ready-1 Phase III Trial
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging Phase 2b Study of Rzl-012 for Submental Fat Reduction